| TalkMarkets | Page 1
No data available
No data available

People who follow this stock (40)

View All

Latest Posts

About This Stock More About This Stock
TG Therapeutics Stock Just Rallied 30%: What Happened?
Article By: Wajeeh Khan
Wednesday, May 1, 2024 9:39 AM EDT
TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter.
In this article: TGTX
Read
My Biotech Investing Advice For 2021
Article By: Marc Lichtenfeld
Tuesday, January 19, 2021 5:05 AM EDT
The J.P. Morgan Healthcare Conference is the most important healthcare investment conference of the year.
In this article: FOLD, NVAX, REGN, TGTX Also: JPM
Read
5 Hot Stocks For The Second Quarter
Article By: TipRanks
Wednesday, March 28, 2018 9:40 AM EDT
As the Q1 roller-coaster draws to a bumpy close, it’s time to move our attention to the coming quarter.
In this article: MTZ, MU, TGTX, META, MDGL
Read
3 ‘Strong Buy’ Biotechs That Can Double In 2018
Article By: TipRanks
Sunday, March 11, 2018 1:00 PM EDT
Biotech stocks often present intriguing investment opportunities- although the rewards can be quickly eradicated if key regulatory approvals are delayed or refused. To minimize the risk, we pinpoint these three compelling stocks.
In this article: TXMD, TGTX, FLKS
Read
TG Therapeutics, Inc. Announces Pricing Of $50 Million Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 9, 2017 3:48 PM EDT
TG Therapeutics, Inc., today announced the pricing of an underwritten public offering of 5,128,206 shares of its common stock at a price of $9.75 per share, with expected gross proceeds to TG Therapeutics of $50 million.
In this article: TGTX
Read
All Posts

Latest Tweets for $TGTX

No tweets yet!

PARTNER HEADLINES